DesJardin Michael A.

CIK 00015129852 companiesPALO ALTO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001512985

Recent Transactions

50 trades

Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−13,753→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2023-10-06$116.50/sh−126,838→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−4,285→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−5,174→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−12,854→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−10,349→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−5,236→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−5,174→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−21,426→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Restricted Stock Units
2023-10-06−10,479→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Restricted Stock Units
2023-10-06−20,697→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−31,436→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Restricted Stock Units
2023-10-06−14,283→ 0 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
2023-03-02−743→ 0 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
2023-03-02−3,629→ 0 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2023-03-02$17.19/sh+743→ 126,558 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2023-03-02$14.93/sh+3,629→ 125,815 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
2023-01-05−10,482→ 5,236 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
2023-01-05−4,834→ 0 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
2023-01-05−1,966→ 0 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
2023-01-05−7,257→ 0 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSUs)
2023-01-05−7,141→ 14,283 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSUs)
2023-01-05−12,095→ 0 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2023-01-05+54,253→ 149,087 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSUs)
2023-01-05−10,478→ 10,479 total
Tax Payment
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2023-01-05$113.24/sh−26,901→ 122,186 total
Award
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSUs)
2023-01-04+20,697→ 20,697 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
2023-01-01−21,772→ 0 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2023-01-01+21,772→ 104,395 total
Tax Payment
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2023-01-01$113.80/sh−9,561→ 94,834 total
Award
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
2022-12-27+15,718→ 15,718 total
Award
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
2022-12-27+21,772→ 21,772 total
Award
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2022-06-01+277→ 82,623 total
Sale
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2022-04-12$112.55/sh−9,150→ 93,410 total
Sale
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2022-04-12$113.60/sh−11,064→ 82,346 total
Sale
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2022-03-02$97.05/sh−21,482→ 116,078 total
Sale
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2022-03-02$97.42/sh−13,518→ 102,560 total
Tax Payment
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2022-01-21$86.42/sh−1,825→ 137,560 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSUs)
2022-01-21−3,679→ 0 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2022-01-21+3,679→ 139,385 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
2022-01-05−9,678→ 4,834 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
2022-01-05−9,222→ 9,223 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
2022-01-05−10,478→ 20,957 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
2022-01-05−12,261→ 0 total
Award
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2022-01-05+32,301→ 176,982 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2022-01-05+53,734→ 144,681 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
2022-01-05−12,095→ 12,095 total
Tax Payment
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2022-01-05$101.84/sh−41,276→ 135,706 total
Award
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
2022-01-04+21,424→ 21,424 total
Award
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
2021-07-28+14,514→ 14,514 total

Companies

Recent Filings

Address

C/O JAZZ PHARMACEUTICALS, INC. 3180 PORTER DRIVE

PALO ALTO, CA, 94304

View on SEC.gov